Innoviva (INVA) Shares Issued (2010 - 2026)
Innoviva posted quarterly Shares Issued of $259000.0 for Q1 2026, up 3.6% year-on-year from $250000.0 in Q1 2025, and down 97.58% on a QoQ basis from $10.7 million in Q3 2025.
Innoviva (INVA) has 17 years of Shares Issued data on file, last reported at $259000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued rose 3.6% year-over-year to $259000.0; the trailing twelve-month figure through Mar 2026 stood at $12.5 million (up 1294.41% YoY), and the FY2025 full-year result was $10.7 million, changed N/A from the prior year.
- Shares Issued for Q1 2026 stood at $259000.0, down from $10.7 million in the prior quarter.
- Across five years, Shares Issued topped out at $10.7 million in Q3 2025 and bottomed at $81000.0 in Q2 2022.
- The 5-year median for Shares Issued is $259000.0 (2026), against an average of $1.3 million.
- The widest annual swing landed in 2023, when Shares Issued tumbled 67.54%; it then soared 709.55% in 2025.
- A 5-year view of Shares Issued shows it stood at $342000.0 in 2022, then sank by 67.54% to $111000.0 in 2023, then surged by 41.44% to $157000.0 in 2024, then jumped by 6715.29% to $10.7 million in 2025, then slumped by 97.58% to $259000.0 in 2026.
- The last three Shares Issued figures came in at $259000.0 (Q1 2026), $10.7 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 259,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259,000.00 |
| Mar 31, 2026 | 259,000.00 |
| Sep 30, 2025 | 10.70 Mn |
| Sep 30, 2025 | 10.70 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 250,000.00 |
| Mar 31, 2025 | 250,000.00 |
| Jun 30, 2024 | 157,000.00 |
| Jun 30, 2024 | 157,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Sep 30, 2023 | 111,000.00 |
| Sep 30, 2023 | 111,000.00 |
| Jun 30, 2023 | 111,000.00 |
| Jun 30, 2023 | 111,000.00 |
| Sep 30, 2022 | 342,000.00 |
| Sep 30, 2022 | 342,000.00 |
| Jun 30, 2022 | 81,000.00 |
| Jun 30, 2022 | 81,000.00 |
| Mar 31, 2022 | 260,000.00 |
| Mar 31, 2022 | 260,000.00 |
| Sep 30, 2021 | 123,000.00 |
| Sep 30, 2021 | 123,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Jun 30, 2020 | 197,000.00 |
| Jun 30, 2020 | 197,000.00 |
| Mar 31, 2020 | 225,000.00 |
| Mar 31, 2020 | 225,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 89,000.00 |
| Sep 30, 2019 | 89,000.00 |
| Jun 30, 2019 | 210,000.00 |
| Jun 30, 2019 | 210,000.00 |
| Mar 31, 2019 | 319,000.00 |
| Mar 31, 2019 | 319,000.00 |
| Dec 31, 2018 | 685,000.00 |
| Dec 31, 2018 | 685,000.00 |
| Jun 30, 2018 | 340,000.00 |
| Jun 30, 2018 | 340,000.00 |
| Mar 31, 2018 | 114,000.00 |
| Mar 31, 2018 | 114,000.00 |
| Dec 31, 2017 | 247,000.00 |
| Dec 31, 2017 | 247,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 177,000.00 |
| Jun 30, 2017 | 177,000.00 |
| Mar 31, 2017 | 8,000.00 |
| Mar 31, 2017 | 8,000.00 |
| Dec 31, 2016 | 44,000.00 |
| Dec 31, 2016 | 44,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Jun 30, 2016 | 162,000.00 |
| Jun 30, 2016 | 162,000.00 |
| Mar 31, 2016 | 173,000.00 |
| Mar 31, 2016 | 173,000.00 |
| Dec 31, 2015 | 123,000.00 |
| Dec 31, 2015 | 123,000.00 |
| Sep 30, 2015 | 3.49 Mn |
| Sep 30, 2015 | 3.49 Mn |
| Jun 30, 2015 | 2.89 Mn |
| Jun 30, 2015 | 2.89 Mn |
| Mar 31, 2015 | 1.75 Mn |
| Mar 31, 2015 | 1.75 Mn |
| Dec 31, 2014 | 18.96 Mn |
| Dec 31, 2014 | 18.96 Mn |
| Sep 30, 2014 | 11.84 Mn |
| Sep 30, 2014 | 11.84 Mn |
| Jun 30, 2014 | 5.51 Mn |
| Jun 30, 2014 | 5.51 Mn |
| Mar 31, 2014 | 18.27 Mn |
| Mar 31, 2014 | 18.27 Mn |
| Dec 31, 2013 | 13.02 Mn |
| Dec 31, 2013 | 13.02 Mn |
| Sep 30, 2013 | 113.57 Mn |
| Sep 30, 2013 | 113.57 Mn |
| Jun 30, 2013 | 23.44 Mn |
| Jun 30, 2013 | 23.44 Mn |
| Mar 31, 2013 | 2.99 Mn |
| Mar 31, 2013 | 2.99 Mn |
| Dec 31, 2012 | 7.16 Mn |
| Dec 31, 2012 | 7.16 Mn |
| Sep 30, 2012 | 12.42 Mn |
| Sep 30, 2012 | 12.42 Mn |
| Jun 30, 2012 | 214.27 Mn |
| Jun 30, 2012 | 214.27 Mn |
| Mar 31, 2012 | 2.53 Mn |
| Mar 31, 2012 | 2.53 Mn |
| Dec 31, 2011 | 2.89 Mn |
| Dec 31, 2011 | 2.89 Mn |
| Sep 30, 2011 | 1.36 Mn |
| Sep 30, 2011 | 1.36 Mn |
| Jun 30, 2011 | 9.82 Mn |
| Jun 30, 2011 | 9.82 Mn |
| Mar 31, 2011 | 11.73 Mn |
| Mar 31, 2011 | 11.73 Mn |
| Dec 31, 2010 | 133.37 Mn |
| Dec 31, 2010 | 133.37 Mn |
| Sep 30, 2010 | 1.44 Mn |
| Sep 30, 2010 | 1.44 Mn |